Drug recall · November 29, 2017
Dexamethasone Sodium Phosphate Injection recall
Why: Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 0641-6146-01), packaged in 25 x 5 mL Vials per shelf pack (NDC 0641-6146-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.
- Lots / codes
Lot #: 106352, Exp 10/18
- Quantity
- 1,896 shelf packs
- Company
- West-Ward Pharmaceuticals Corp., Eatontown, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- November 6, 2017 · Voluntary: Firm initiated
- Classified
- November 22, 2017
- Reported
- November 29, 2017
- Ended
- April 1, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dexamethasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.